Grade III arteriovenous malformations (AVMs) are diverse because of their variations in size (S), location in eloquent cortex (E), and presence of central venous drainage (V). Because they may have implications for management and outcome, the authors evaluated these variations in the present study.
Between 1984 and 2010, 100 patients with Grade III AVMs were treated. The AVMs were categorized by Spetzler-Martin characteristics as follows: Type 1 = S1E1V1, Type 2 = S2E1V0, Type 3 = S2E0V1, and Type 4 = S3E0V0. The occurrence of a new neurological deficit, functional status (based on modified Rankin Scale [mRS] score) at discharge and follow-up, and radiological obliteration were correlated with demographic and morphological characteristics.
One hundred patients (49 female and 51 male; age range 5–68 years, mean 35.8 years) were evaluated. The size of AVMs was less than 3 cm in 28 patients, 3–6 cm in 71, and greater than 6 cm in 1; 86 AVMs were located in eloquent cortex and 38 had central drainage. The AVMs were Type 1 in 28 cases, Type 2 in 60, Type 3 in 11, and Type 4 in 1. The authors performed embolization in 77 patients (175 procedures), surgery in 64 patients (74 surgeries), and radiosurgery in 49 patients (44 primary and 5 postoperative).
The mortality rate following the management of these AVMs was 1%. Fourteen patients (14%) had new neurological deficits, with 5 (5%) being disabling (mRS score > 2) and 9 (9%) being nondisabling (mRS score ≤ 2) events. Patients with Type 1 AVMs (small size) had the best outcome, with 1 (3.6%) in 28 having a new neurological deficit, compared with 72 patients with larger AVMs, of whom 13 (18.1%) had a new neurological deficit (p < 0.002). Older age (> 40 years), malformation size > 3 cm, and nonhemorrhagic presentation predicted the occurrence of new deficits (p < 0.002). Sex, eloquent cortex, and venous drainage did not confer any benefit.
In 89 cases follow-up was adequate for data to be included in the obliteration analysis. The AVM was obliterated in 78 patients (87.6%), 69 of them (88.5%) demonstrated on angiography and 9 on MRI /MR angiography. There was no difference between obliteration rates between different types of AVMs, size, eloquence, and drainage. Age, sex, and clinical presentation also did not predict obliteration.
Multimodality management of Grade III AVMs results in a high rate of obliteration, which was not influenced by size, venous drainage, or eloquent location. However, the development of new neurological deficits did correlate with size, whereas eloquence and venous drainage did not affect the neurological complication rate. The authors propose subclassifying the Grade III AVMs according to their size (< 3 and ≥ 3 cm) to account for treatment risk.
Abbreviations used in this paper:AVM = arteriovenous malformation; MRA = MR angiography; mRS = modified Rankin Scale.
Address correspondence to: Gary K. Steinberg, M.D., Ph.D., R281, Department of Neurosurgery, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, California 94305-5327. email: firstname.lastname@example.org.
Please include this information when citing this paper: published online April 6, 2012; DOI: 10.3171/2012.3.JNS111575.
Andrade-SouzaYMZadehGRamaniMScoraDTsaoMNSchwartzML: Testing the radiosurgery-based arteriovenous malformation score and the modified Spetzler-Martin grading system to predict radiosurgical outcome. J Neurosurg103:642–6482005
DavidsonASMorganMK: How safe is arteriovenous malformation surgery? A prospective, observational study of surgery as first-line treatment for brain arteriovenous malformations. Neurosurgery66:498–5052010
DerutyRPelissou-GuyotatIMottoleseCAmatDBascoulergueY: Prognostic value of the Spetzler's grading system in a series of cerebral AVMs treated by a combined management. Acta Neurochir (Wien)131:169–1751994
DuRKeyoungHMDowdCFYoungWLLawtonMT: The effects of diffuseness and deep perforating artery supply on outcomes after microsurgical resection of brain arteriovenous malformations. Neurosurgery60:638–6482007
LohYDuckwilerGR: A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article. J Neurosurg113:733–7412010
PellettieriLCarlssonCAGrevstenSNorlénGUhlemannC: Surgical versus conservative treatment of intracranial arteriovenous malformations: a study in surgical decision-making. Acta Neurochir Suppl (Wien)29:1–861979
PertuisetBAncriDKinutaYHaisaTBordiLLinC: Classification of supratentorial arteriovenous malformations. A score system for evaluation of operability and surgical strategy based on an analysis of 66 cases. Acta Neurochir (Wien)110:6–161991
SpearsJTerbruggeKGMoosavianMMontaneraWWillinskyRAWallaceMC: A discriminative prediction model of neurological outcome for patients undergoing surgery of brain arteriovenous malformations. Stroke37:1457–14642006
WedderburnCJvan BeijnumJBhattacharyaJJCounsellCEPapanastassiouVRitchieV: Outcome after interventional or conservative management of unruptured brain arteriovenous malformations: a prospective, population-based cohort study. Lancet Neurol7:223–2302008